Thomas Paul
- SEC CIK
- 0001166776
In the past year, 1 open-market sale filing worth $633.6K and no purchases.
Current role at each company
- AXGN Axogen, Inc.Directoras of Jun 26, 2026
- TELA TELA Bio, Inc.Directoras of Jun 11, 2026
- ABMD Abiomed IncDirectoras of Dec 27, 2022
- SRGA Surgalign Holdings, Inc.Directoras of Aug 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $633.6K
- 1 filing
- Net
- −$633.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Thomas Paul as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AXGN Axogen, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 (view filing) | Dec 9 | 1 day | Thomas PaulDirector | SSale | −21.4K | $29.61 | −$633.6K | −61.3%13.5K after |
ABMD Abiomed Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2022 (view filing) | Nov 1 | 2 days | Thomas PaulDirector | SSaleCommon Stock, $.01 par value | −1.00K | $379.38 | −$379.4K | −13.6%6.36K after | |
| Aug 19, 2021 (view filing) | Aug 18 | 1 day | Thomas PaulDirector | SSaleCommon Stock, $.01 par value | −663 | $330.77 | −$219.3K | −8.8%6.91K after |